Variables | Level | Overall (N = 180) | HR (95% CI) | P-value | HR (95% CI) | P-value |
---|---|---|---|---|---|---|
Age (median [IQR]) |  | 66.0 (59.0, 75.0) | 1.02 (1–1.03) | 0.017 | 1.01 (1–1.02) | 0.1986 |
Race (%) | Black | 15 (8.3) | Reference | Â | / | Â |
 | Others | 14 (7.8) | 1.64 (0.77–3.53) | 0.201 | / |  |
 | White | 151 (83.9) | 1.26 (0.71–2.24) | 0.427 | / |  |
Sex (%) | Female | 72 (40.0) | Reference | Â | / | Â |
 | Male | 108 (60.0) | 1.1 (0.81–1.5) | 0.545 | / |  |
Grade (%) | Moderately | 22 (12.2) | Reference | Â | Reference | Â |
 | Poorly | 150 (83.3) | 2.41 (1.43–4.08) | 0.001 | 1.9 (1.11–3.25) | 0.0195 |
 | Undifferentiated | 8 (4.4) | 2.38 (0.98–5.79) | 0.056 | 0.83 (0.29–2.42) | 0.7361 |
Marital status (%) | Married | 102 (56.7) | Reference | Â | Â | Â |
 | Unmarried | 78 (43.3) | 1.17 (0.86–1.59) | 0.314 | / |  |
Primary site (%) | Body | 17 (9.4) | Reference | Â | / | Â |
 | Head | 107 (59.4) | 0.8 (0.47–1.37) | 0.423 | / |  |
 | Others | 39 (21.7) | 1.8 (1–3.24) | 0.052 | / |  |
 | Tail | 17 (9.4) | 1.19 (0.59–2.39) | 0.622 | / |  |
AJCC stage (%) | I | 7 (3.9) | Reference | Â | Reference | Â |
 | II | 71 (39.4) | 1.27 (0.51–3.17) | 0.606 | 1.91 (0.76–4.82) | 0.1714 |
 | III | 18 (10.0) | 2.2 (0.81–5.98) | 0.121 | 1.95 (0.71–5.36) | 0.1930 |
 | IV | 84 (46.7) | 3.72 (1.5–9.27) | 0.005 | 2.98 (1.16–7.65) | 0.0232 |
Surgery (%) | No | 111 (61.7) | Reference | Â | Reference | Â |
 | Yes | 69 (38.3) | 0.27 (0.19–0.39) | < 0.001 | 0.27 (0.18–0.42) | < 0.001 |
Chemotherapy (%) | No/unknown | 86 (47.8) | Reference | Â | Reference | Â |
 | Yes | 94 (52.2) | 0.46 (0.34–0.63) | < 0.001 | 0.33 (0.22–0.48) | < 0.001 |
Radiation (%) | Yes | 38 (21.1) | Reference | Â | Reference | Â |
 | None/unknown | 142 (78.9) | 1.93 (1.32–2.82) | 0.001 | 0.85 (0.54–1.35) | 0.4887 |